Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Disasters Averted Previous | All Articles This Week | Next
This article originally posted and appeared in  Safety and Error PreventionBG ControlMedical DevicesCMS2Special Edition - Best of 2010Patient ErrorsDiabetes Clinical Mastery Series Issue 176

Insulin Pump Mystery

"One of our pump-using patients reported a sudden increase in blood glucose lasting several days. No ketones were present, but the blood glucose was chronically elevated (300 mg/dl plus). Changing infusion sets didn't fix it. Rotating to a new body part nor did switching to a fresh vial of insulin. We noticed a symbol on their "home screen" denoting that a special feature was running. Upon investigating, we found that they accidentally switched the pump to a secondary basal pattern with the rate set at 0.0 units/hr. Reverting back to their standard basal program and deactivating the extra basal programs led to immediate resolution."

Advertisement

Bottom Line:

As a pump trainer I know that often times when it comes to how to change pump settings most patients don’t have a clue. This happens because they may go for a very long time on the first settings in their pump and never get a chance to practice. Setting a second basal program happens quite often as the patient sees their clinician and is instructed to change rates but is not sure how to do it and accidently sets up a second bolus. Experience shows that many users feel if they go back to the home screen they can undo whatever they have done. As a way to protect your patients from this, ask them to call the support center of their respective company and let them walk the patient through the changes. -- Dave Joffe, Editor-in-chief

Report Medication Errors to ISMP:

Diabetes in Control is partnered with the Institute for Safe Medication Practices (ISMP) to help ensure errors and near-miss events get reported and shared with millions of health care practitioners. The ISMP is a Patient Safety Organization obligated by law to maintain the anonymity of anyone involved, as well as omitting or changing contextual details for that purpose. Help save lives and protect patients and colleagues by confidentially reporting errors to the ISMP.

Report_Now

*****

And if you have a "Diabetes Disaster Averted" story, please also send it in separately to Diabetes In Control. If we use it you will receive a Visa Gift Card worth $50.00. Click here to let us know the details. (You can use your name or remain anonymous if you prefer.) Please note that ISMP is not associated with this Gift Card promotion.

Copyright © 2010 Diabetes In Control, Inc.

←Previous Diabetes Disaster Averted 
U-500 Pharmacy Error

 

Next Diabetes Disaster Averted 
Abbreviations Will Get U in Trouble

For the complete list of Diabetes Disasters Averted, just follow this link. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 12 October, 2010 and appeared in  Safety and Error PreventionBG ControlMedical DevicesCMS2Special Edition - Best of 2010Patient ErrorsDiabetes Clinical Mastery Series Issue 176

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?